[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f1EkStBhgCg1xdGzihZp2MTndLbJYPKvBVXyJbbK_k5s":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":65,"rows":72},"Children's Mercy Hospital Kansas City",[4],207,false,26,11,42097,8,160,[14,17,20,23,25,27,30,32],{"name":15,"count":16},"Type 1 Diabetes",7,{"name":18,"count":19},"Asthma",6,{"name":21,"count":22},"Type 1 Diabetes Mellitus",5,{"name":24,"count":22},"Obesity",{"name":26,"count":22},"Contraception",{"name":28,"count":29},"Congenital Heart Disease",4,{"name":31,"count":29},"Physical Activity",{"name":33,"count":29},"Perforated Appendicitis",[35,40,45,50,55,60],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT04903223","Liver Adiposity Effects on Pediatric Statin","2026-06-30","Rosuvastatin 10mg",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT06834594","Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome","2026-07-30","Micronized progesterone 200 MG",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT05509257","Naltrexone Neuroimaging in Teens With Eating Disorders","2026-09","Naltrexone",{"nctId":51,"briefTitle":52,"date":53,"intervention":54},"NCT06324396","IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease","2026-12-31","Sildenafil 10mg oral",{"nctId":56,"briefTitle":57,"date":58,"intervention":59},"NCT07195032","Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients","2027-09-11","Commercial measles, mumps, and rubella (MMR) vaccine",{"nctId":61,"briefTitle":62,"date":63,"intervention":64},"NCT06554288","Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy","2029-11-30","Trihexyphenidyl",[66,67,68,69,70,71],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[73,97,121,139,160,188,210,228,265,302,329,347,374,392,410,436,465,483,507,533,559,583,601,625,651,682,700,718,736,754,772,790,816,842,860,886,912,939,964,987,1016,1052,1079,1112,1138,1166,1191,1209,1236,1254,1272,1297,1322,1340,1366,1391,1409,1432,1450,1477,1495,1519,1545,1563,1588,1606],{"intervention":59,"totalTrials":74,"cells":75},1,{"EARLY_PHASE1":76,"PHASE1":79,"PHASE2":81,"PHASE3":83,"PHASE4":85,"NA":95},{"trials":77,"activeCount":78},[],0,{"trials":80,"activeCount":78},[],{"trials":82,"activeCount":78},[],{"trials":84,"activeCount":78},[],{"trials":86,"activeCount":74,"soonestReadout":58},[87],{"nctId":56,"briefTitle":57,"status":88,"phases":89,"primaryCompletion":58,"completion":58,"start":90,"enrollment":91,"conditions":92,"interventions":94},"RECRUITING",[70],"2025-09-11",60,[93],"Heart Transplant Infection Prevention",[59],{"trials":96,"activeCount":78},[],{"intervention":44,"totalTrials":74,"cells":98},{"EARLY_PHASE1":99,"PHASE1":101,"PHASE2":103,"PHASE3":105,"PHASE4":107,"NA":119},{"trials":100,"activeCount":78},[],{"trials":102,"activeCount":78},[],{"trials":104,"activeCount":78},[],{"trials":106,"activeCount":78},[],{"trials":108,"activeCount":74,"soonestReadout":43},[109],{"nctId":41,"briefTitle":42,"status":88,"phases":110,"primaryCompletion":43,"completion":111,"start":112,"enrollment":113,"conditions":114,"interventions":117},[70],"2026-07-31","2025-07-31",40,[115,116],"Turner Syndrome","Primary Ovarian Insufficiency (Poi)",[44,118],"Micronized Progesterone 100 MG",{"trials":120,"activeCount":78},[],{"intervention":118,"totalTrials":74,"cells":122},{"EARLY_PHASE1":123,"PHASE1":125,"PHASE2":127,"PHASE3":129,"PHASE4":131,"NA":137},{"trials":124,"activeCount":78},[],{"trials":126,"activeCount":78},[],{"trials":128,"activeCount":78},[],{"trials":130,"activeCount":78},[],{"trials":132,"activeCount":74,"soonestReadout":43},[133],{"nctId":41,"briefTitle":42,"status":88,"phases":134,"primaryCompletion":43,"completion":111,"start":112,"enrollment":113,"conditions":135,"interventions":136},[70],[115,116],[44,118],{"trials":138,"activeCount":78},[],{"intervention":39,"totalTrials":74,"cells":140},{"EARLY_PHASE1":141,"PHASE1":143,"PHASE2":152,"PHASE3":154,"PHASE4":156,"NA":158},{"trials":142,"activeCount":78},[],{"trials":144,"activeCount":74,"soonestReadout":38},[145],{"nctId":36,"briefTitle":37,"status":88,"phases":146,"primaryCompletion":38,"completion":53,"start":147,"enrollment":148,"conditions":149,"interventions":151},[67],"2021-04-01",50,[150],"Cholesterol; Lipidosis",[39],{"trials":153,"activeCount":78},[],{"trials":155,"activeCount":78},[],{"trials":157,"activeCount":78},[],{"trials":159,"activeCount":78},[],{"intervention":64,"totalTrials":74,"cells":161},{"EARLY_PHASE1":162,"PHASE1":164,"PHASE2":180,"PHASE3":182,"PHASE4":184,"NA":186},{"trials":163,"activeCount":78},[],{"trials":165,"activeCount":74,"soonestReadout":63},[166],{"nctId":61,"briefTitle":62,"status":88,"phases":167,"primaryCompletion":63,"completion":168,"start":169,"enrollment":113,"conditions":170,"interventions":179},[67],"2029-12-31","2024-10-15",[171,172,173,174,175,176,177,178],"Pediatric Disorder","Genetic Predisposition","Dystonia, Secondary","Dystonia","Cerebral Palsy, Dystonic-Rigid","Cerebral Palsy, Dyskinetic","Trihexyphenidyl Adverse Reaction","Pharmacogenomic Drug Interaction",[64],{"trials":181,"activeCount":78},[],{"trials":183,"activeCount":78},[],{"trials":185,"activeCount":78},[],{"trials":187,"activeCount":78},[],{"intervention":54,"totalTrials":74,"cells":189},{"EARLY_PHASE1":190,"PHASE1":192,"PHASE2":202,"PHASE3":204,"PHASE4":206,"NA":208},{"trials":191,"activeCount":78},[],{"trials":193,"activeCount":74,"soonestReadout":53},[194],{"nctId":51,"briefTitle":52,"status":88,"phases":195,"primaryCompletion":53,"completion":53,"start":196,"enrollment":197,"conditions":198,"interventions":200},[67],"2024-03-01",15,[199],"Fontan Circulation",[54,201],"Pravastatin 20 mg oral",{"trials":203,"activeCount":78},[],{"trials":205,"activeCount":78},[],{"trials":207,"activeCount":78},[],{"trials":209,"activeCount":78},[],{"intervention":201,"totalTrials":74,"cells":211},{"EARLY_PHASE1":212,"PHASE1":214,"PHASE2":220,"PHASE3":222,"PHASE4":224,"NA":226},{"trials":213,"activeCount":78},[],{"trials":215,"activeCount":74,"soonestReadout":53},[216],{"nctId":51,"briefTitle":52,"status":88,"phases":217,"primaryCompletion":53,"completion":53,"start":196,"enrollment":197,"conditions":218,"interventions":219},[67],[199],[54,201],{"trials":221,"activeCount":78},[],{"trials":223,"activeCount":78},[],{"trials":225,"activeCount":78},[],{"trials":227,"activeCount":78},[],{"intervention":49,"totalTrials":229,"cells":230},2,{"EARLY_PHASE1":231,"PHASE1":255,"PHASE2":257,"PHASE3":259,"PHASE4":261,"NA":263},{"trials":232,"activeCount":74,"soonestReadout":48},[233,244],{"nctId":46,"briefTitle":47,"status":88,"phases":234,"primaryCompletion":48,"completion":235,"start":236,"enrollment":91,"conditions":237,"interventions":243},[66],"2027-06","2022-09-17",[238,239,240,241,242],"Eating Disorders","Binge Eating","Purging (Eating Disorders)","Bulimia Nervosa","Anorexia Nervosa, Atypical",[49],{"nctId":245,"briefTitle":246,"status":247,"phases":248,"primaryCompletion":249,"completion":250,"start":251,"enrollment":252,"conditions":253,"interventions":254},"NCT04935931","Naltrexone Neuroimaging","COMPLETED",[66],"2022-06-15","2022-06-30","2021-07-16",13,[238,239,240],[49],{"trials":256,"activeCount":78},[],{"trials":258,"activeCount":78},[],{"trials":260,"activeCount":78},[],{"trials":262,"activeCount":78},[],{"trials":264,"activeCount":78},[],{"intervention":266,"totalTrials":229,"cells":267},"Pantoprazole",{"EARLY_PHASE1":268,"PHASE1":270,"PHASE2":282,"PHASE3":284,"PHASE4":286,"NA":300},{"trials":269,"activeCount":78},[],{"trials":271,"activeCount":78},[272],{"nctId":273,"briefTitle":274,"status":247,"phases":275,"primaryCompletion":276,"completion":276,"start":277,"enrollment":278,"conditions":279,"interventions":281},"NCT01887743","Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD: A Pilot Study",[67],"2015-10","2013-06",71,[24,280],"GERD",[266],{"trials":283,"activeCount":78},[],{"trials":285,"activeCount":78},[],{"trials":287,"activeCount":78},[288],{"nctId":289,"briefTitle":290,"status":247,"phases":291,"primaryCompletion":292,"completion":292,"start":293,"enrollment":294,"conditions":295,"interventions":298},"NCT04248335","Effect of Obesity on Proton Pump Inhibitors",[70],"2024-12-31","2018-07-03",150,[296,297,280],"Pediatric Obesity","NAFLD",[266,299],"Midazolam",{"trials":301,"activeCount":78},[],{"intervention":303,"totalTrials":74,"cells":304},"Liquid stable levothyroxine (L-T4) Tirosint-SOL",{"EARLY_PHASE1":305,"PHASE1":307,"PHASE2":309,"PHASE3":311,"PHASE4":313,"NA":327},{"trials":306,"activeCount":78},[],{"trials":308,"activeCount":78},[],{"trials":310,"activeCount":78},[],{"trials":312,"activeCount":78},[],{"trials":314,"activeCount":78},[315],{"nctId":316,"briefTitle":317,"status":318,"phases":319,"primaryCompletion":320,"completion":320,"start":321,"enrollment":19,"conditions":322,"interventions":325},"NCT04747275","Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients","TERMINATED",[70],"2021-11-01","2021-01-18",[323,324],"Hypothyroidism","Trisomy 21",[303,326],"Oral tablet levothyroxine",{"trials":328,"activeCount":78},[],{"intervention":326,"totalTrials":74,"cells":330},{"EARLY_PHASE1":331,"PHASE1":333,"PHASE2":335,"PHASE3":337,"PHASE4":339,"NA":345},{"trials":332,"activeCount":78},[],{"trials":334,"activeCount":78},[],{"trials":336,"activeCount":78},[],{"trials":338,"activeCount":78},[],{"trials":340,"activeCount":78},[341],{"nctId":316,"briefTitle":317,"status":318,"phases":342,"primaryCompletion":320,"completion":320,"start":321,"enrollment":19,"conditions":343,"interventions":344},[70],[323,324],[303,326],{"trials":346,"activeCount":78},[],{"intervention":348,"totalTrials":74,"cells":349},"Hydrocodone\u002Facetaminophen",{"EARLY_PHASE1":350,"PHASE1":352,"PHASE2":354,"PHASE3":356,"PHASE4":358,"NA":372},{"trials":351,"activeCount":78},[],{"trials":353,"activeCount":78},[],{"trials":355,"activeCount":78},[],{"trials":357,"activeCount":78},[],{"trials":359,"activeCount":78},[360],{"nctId":361,"briefTitle":362,"status":247,"phases":363,"primaryCompletion":364,"completion":364,"start":365,"enrollment":366,"conditions":367,"interventions":369},"NCT06187584","Supracondylar Humerus Fracture (SCHF) Post-Op Study Between Opioid and Non-Opioid Pain Management",[70],"2023-12-20","2019-04-15",137,[368],"Supracondylar Humerus Fracture",[348,370,371],"Acetaminophen","Ibuprofen",{"trials":373,"activeCount":78},[],{"intervention":370,"totalTrials":74,"cells":375},{"EARLY_PHASE1":376,"PHASE1":378,"PHASE2":380,"PHASE3":382,"PHASE4":384,"NA":390},{"trials":377,"activeCount":78},[],{"trials":379,"activeCount":78},[],{"trials":381,"activeCount":78},[],{"trials":383,"activeCount":78},[],{"trials":385,"activeCount":78},[386],{"nctId":361,"briefTitle":362,"status":247,"phases":387,"primaryCompletion":364,"completion":364,"start":365,"enrollment":366,"conditions":388,"interventions":389},[70],[368],[348,370,371],{"trials":391,"activeCount":78},[],{"intervention":371,"totalTrials":74,"cells":393},{"EARLY_PHASE1":394,"PHASE1":396,"PHASE2":398,"PHASE3":400,"PHASE4":402,"NA":408},{"trials":395,"activeCount":78},[],{"trials":397,"activeCount":78},[],{"trials":399,"activeCount":78},[],{"trials":401,"activeCount":78},[],{"trials":403,"activeCount":78},[404],{"nctId":361,"briefTitle":362,"status":247,"phases":405,"primaryCompletion":364,"completion":364,"start":365,"enrollment":366,"conditions":406,"interventions":407},[70],[368],[348,370,371],{"trials":409,"activeCount":78},[],{"intervention":411,"totalTrials":74,"cells":412},"Caffeine",{"EARLY_PHASE1":413,"PHASE1":415,"PHASE2":417,"PHASE3":419,"PHASE4":421,"NA":434},{"trials":414,"activeCount":78},[],{"trials":416,"activeCount":78},[],{"trials":418,"activeCount":78},[],{"trials":420,"activeCount":78},[],{"trials":422,"activeCount":78},[423],{"nctId":424,"briefTitle":425,"status":247,"phases":426,"primaryCompletion":427,"completion":428,"start":429,"enrollment":430,"conditions":431,"interventions":433},"NCT04950660","Oral Caffeine Use for Pain Management in AIS Patients After Spinal Fusion",[70],"2024-01-20","2024-08-01","2019-12-11",61,[432],"Adolescent Idiopathic Scoliosis",[411],{"trials":435,"activeCount":78},[],{"intervention":437,"totalTrials":74,"cells":438},"Contrast Enhanced Ultrasound",{"EARLY_PHASE1":439,"PHASE1":441,"PHASE2":443,"PHASE3":445,"PHASE4":447,"NA":463},{"trials":440,"activeCount":78},[],{"trials":442,"activeCount":78},[],{"trials":444,"activeCount":78},[],{"trials":446,"activeCount":78},[],{"trials":448,"activeCount":78},[449],{"nctId":450,"briefTitle":451,"status":452,"phases":453,"primaryCompletion":454,"completion":455,"start":456,"enrollment":78,"conditions":457,"interventions":462},"NCT03963999","Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients","WITHDRAWN",[70],"2024-04-30","2025-04-01","2020-04-01",[458,459,460,461],"Sinusoidal Obstruction Syndrome","Veno Occlusive Disease, Hepatic","Bone Marrow Transplant Complications","Stem Cell Transplant Complications",[437],{"trials":464,"activeCount":78},[],{"intervention":299,"totalTrials":74,"cells":466},{"EARLY_PHASE1":467,"PHASE1":469,"PHASE2":471,"PHASE3":473,"PHASE4":475,"NA":481},{"trials":468,"activeCount":78},[],{"trials":470,"activeCount":78},[],{"trials":472,"activeCount":78},[],{"trials":474,"activeCount":78},[],{"trials":476,"activeCount":78},[477],{"nctId":289,"briefTitle":290,"status":247,"phases":478,"primaryCompletion":292,"completion":292,"start":293,"enrollment":294,"conditions":479,"interventions":480},[70],[296,297,280],[266,299],{"trials":482,"activeCount":78},[],{"intervention":484,"totalTrials":74,"cells":485},"Omegaven",{"EARLY_PHASE1":486,"PHASE1":488,"PHASE2":490,"PHASE3":492,"PHASE4":503,"NA":505},{"trials":487,"activeCount":78},[],{"trials":489,"activeCount":78},[],{"trials":491,"activeCount":78},[],{"trials":493,"activeCount":78},[494],{"nctId":495,"briefTitle":496,"status":247,"phases":497,"primaryCompletion":498,"completion":498,"start":499,"enrollment":229,"conditions":500,"interventions":502},"NCT04697888","Use of Omegaven for Treatment With Parenteral Nutrition Associated Liver Disease",[68,69],"2018-11","2013-04",[501],"Parenteral Nutrition-related Hepatitis",[484],{"trials":504,"activeCount":78},[],{"trials":506,"activeCount":78},[],{"intervention":508,"totalTrials":74,"cells":509},"Levocetirizine 0.5 Mg\u002FmL Oral Solution",{"EARLY_PHASE1":510,"PHASE1":512,"PHASE2":514,"PHASE3":516,"PHASE4":529,"NA":531},{"trials":511,"activeCount":78},[],{"trials":513,"activeCount":78},[],{"trials":515,"activeCount":78},[],{"trials":517,"activeCount":78},[518],{"nctId":519,"briefTitle":520,"status":247,"phases":521,"primaryCompletion":522,"completion":522,"start":523,"enrollment":524,"conditions":525,"interventions":528},"NCT01392859","Characterization of the Role of Histamine in Children With Asthma",[68,69],"2015-03-29","2011-06",211,[18,526,527],"Allergic Asthma","Non-allergic Asthma",[508],{"trials":530,"activeCount":78},[],{"trials":532,"activeCount":78},[],{"intervention":534,"totalTrials":74,"cells":535},"Metformin and Spironolactone",{"EARLY_PHASE1":536,"PHASE1":538,"PHASE2":540,"PHASE3":542,"PHASE4":555,"NA":557},{"trials":537,"activeCount":78},[],{"trials":539,"activeCount":78},[],{"trials":541,"activeCount":78},[],{"trials":543,"activeCount":78},[544],{"nctId":545,"briefTitle":546,"status":247,"phases":547,"primaryCompletion":548,"completion":549,"start":550,"enrollment":551,"conditions":552,"interventions":554},"NCT03981861","Metabolic and Neuro-Endocrine Effect of Treating PCOS in Adolescents",[68,69],"2018-07-09","2019-06-05","2016-07-02",12,[553],"PCOS",[534],{"trials":556,"activeCount":78},[],{"trials":558,"activeCount":78},[],{"intervention":560,"totalTrials":74,"cells":561},"tPA alone",{"EARLY_PHASE1":562,"PHASE1":564,"PHASE2":566,"PHASE3":568,"PHASE4":579,"NA":581},{"trials":563,"activeCount":78},[],{"trials":565,"activeCount":78},[],{"trials":567,"activeCount":78},[],{"trials":569,"activeCount":78},[570],{"nctId":571,"briefTitle":572,"status":452,"phases":573,"primaryCompletion":574,"completion":574,"start":574,"enrollment":78,"conditions":575,"interventions":577},"NCT01862458","Empyema Treated With tPA & DNAse",[69],"2016-01",[576],"Empyema",[560,578],"tPA plus dornase",{"trials":580,"activeCount":78},[],{"trials":582,"activeCount":78},[],{"intervention":578,"totalTrials":74,"cells":584},{"EARLY_PHASE1":585,"PHASE1":587,"PHASE2":589,"PHASE3":591,"PHASE4":597,"NA":599},{"trials":586,"activeCount":78},[],{"trials":588,"activeCount":78},[],{"trials":590,"activeCount":78},[],{"trials":592,"activeCount":78},[593],{"nctId":571,"briefTitle":572,"status":452,"phases":594,"primaryCompletion":574,"completion":574,"start":574,"enrollment":78,"conditions":595,"interventions":596},[69],[576],[560,578],{"trials":598,"activeCount":78},[],{"trials":600,"activeCount":78},[],{"intervention":602,"totalTrials":74,"cells":603},"Nutropin AQ",{"EARLY_PHASE1":604,"PHASE1":606,"PHASE2":608,"PHASE3":610,"PHASE4":621,"NA":623},{"trials":605,"activeCount":78},[],{"trials":607,"activeCount":78},[],{"trials":609,"activeCount":78},[],{"trials":611,"activeCount":78},[612],{"nctId":613,"briefTitle":614,"status":247,"phases":615,"primaryCompletion":616,"completion":616,"start":617,"enrollment":9,"conditions":618,"interventions":620},"NCT00444964","Growth Hormone Use in Adults With Prader-Willi Syndrome",[69],"2012-01-01","2005-04",[619],"Prader-Willi Syndrome",[602],{"trials":622,"activeCount":78},[],{"trials":624,"activeCount":78},[],{"intervention":626,"totalTrials":74,"cells":627},"Sulfur hexafluoride lipid-type A microspheres",{"EARLY_PHASE1":628,"PHASE1":630,"PHASE2":632,"PHASE3":645,"PHASE4":647,"NA":649},{"trials":629,"activeCount":78},[],{"trials":631,"activeCount":78},[],{"trials":633,"activeCount":78},[634],{"nctId":635,"briefTitle":636,"status":247,"phases":637,"primaryCompletion":638,"completion":639,"start":640,"enrollment":641,"conditions":642,"interventions":644},"NCT03687502","The Role of Contrast Enhanced Ultrasound in Appendicitis",[68],"2021-03-26","2022-07-05","2019-01-04",37,[643],"Acute Appendicitis",[626],{"trials":646,"activeCount":78},[],{"trials":648,"activeCount":78},[],{"trials":650,"activeCount":78},[],{"intervention":652,"totalTrials":74,"cells":653},"Velcade",{"EARLY_PHASE1":654,"PHASE1":656,"PHASE2":658,"PHASE3":676,"PHASE4":678,"NA":680},{"trials":655,"activeCount":78},[],{"trials":657,"activeCount":78},[],{"trials":659,"activeCount":78},[660],{"nctId":661,"briefTitle":662,"status":318,"phases":663,"primaryCompletion":664,"completion":664,"start":665,"enrollment":229,"conditions":666,"interventions":669},"NCT02535806","Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults",[68],"2017-05-25","2015-07",[667,668],"Acute Lymphoblastic Leukemia","Lymphoblastic Lymphoma",[652,670,671,672,673,674,675],"Methotrexate","Methotrexate \u002F Hydrocortisone \u002F Cytarabine","Dexamethasone","Mitoxantrone","Vincristine","Pegaspargase",{"trials":677,"activeCount":78},[],{"trials":679,"activeCount":78},[],{"trials":681,"activeCount":78},[],{"intervention":670,"totalTrials":74,"cells":683},{"EARLY_PHASE1":684,"PHASE1":686,"PHASE2":688,"PHASE3":694,"PHASE4":696,"NA":698},{"trials":685,"activeCount":78},[],{"trials":687,"activeCount":78},[],{"trials":689,"activeCount":78},[690],{"nctId":661,"briefTitle":662,"status":318,"phases":691,"primaryCompletion":664,"completion":664,"start":665,"enrollment":229,"conditions":692,"interventions":693},[68],[667,668],[652,670,671,672,673,674,675],{"trials":695,"activeCount":78},[],{"trials":697,"activeCount":78},[],{"trials":699,"activeCount":78},[],{"intervention":671,"totalTrials":74,"cells":701},{"EARLY_PHASE1":702,"PHASE1":704,"PHASE2":706,"PHASE3":712,"PHASE4":714,"NA":716},{"trials":703,"activeCount":78},[],{"trials":705,"activeCount":78},[],{"trials":707,"activeCount":78},[708],{"nctId":661,"briefTitle":662,"status":318,"phases":709,"primaryCompletion":664,"completion":664,"start":665,"enrollment":229,"conditions":710,"interventions":711},[68],[667,668],[652,670,671,672,673,674,675],{"trials":713,"activeCount":78},[],{"trials":715,"activeCount":78},[],{"trials":717,"activeCount":78},[],{"intervention":672,"totalTrials":74,"cells":719},{"EARLY_PHASE1":720,"PHASE1":722,"PHASE2":724,"PHASE3":730,"PHASE4":732,"NA":734},{"trials":721,"activeCount":78},[],{"trials":723,"activeCount":78},[],{"trials":725,"activeCount":78},[726],{"nctId":661,"briefTitle":662,"status":318,"phases":727,"primaryCompletion":664,"completion":664,"start":665,"enrollment":229,"conditions":728,"interventions":729},[68],[667,668],[652,670,671,672,673,674,675],{"trials":731,"activeCount":78},[],{"trials":733,"activeCount":78},[],{"trials":735,"activeCount":78},[],{"intervention":673,"totalTrials":74,"cells":737},{"EARLY_PHASE1":738,"PHASE1":740,"PHASE2":742,"PHASE3":748,"PHASE4":750,"NA":752},{"trials":739,"activeCount":78},[],{"trials":741,"activeCount":78},[],{"trials":743,"activeCount":78},[744],{"nctId":661,"briefTitle":662,"status":318,"phases":745,"primaryCompletion":664,"completion":664,"start":665,"enrollment":229,"conditions":746,"interventions":747},[68],[667,668],[652,670,671,672,673,674,675],{"trials":749,"activeCount":78},[],{"trials":751,"activeCount":78},[],{"trials":753,"activeCount":78},[],{"intervention":674,"totalTrials":74,"cells":755},{"EARLY_PHASE1":756,"PHASE1":758,"PHASE2":760,"PHASE3":766,"PHASE4":768,"NA":770},{"trials":757,"activeCount":78},[],{"trials":759,"activeCount":78},[],{"trials":761,"activeCount":78},[762],{"nctId":661,"briefTitle":662,"status":318,"phases":763,"primaryCompletion":664,"completion":664,"start":665,"enrollment":229,"conditions":764,"interventions":765},[68],[667,668],[652,670,671,672,673,674,675],{"trials":767,"activeCount":78},[],{"trials":769,"activeCount":78},[],{"trials":771,"activeCount":78},[],{"intervention":675,"totalTrials":74,"cells":773},{"EARLY_PHASE1":774,"PHASE1":776,"PHASE2":778,"PHASE3":784,"PHASE4":786,"NA":788},{"trials":775,"activeCount":78},[],{"trials":777,"activeCount":78},[],{"trials":779,"activeCount":78},[780],{"nctId":661,"briefTitle":662,"status":318,"phases":781,"primaryCompletion":664,"completion":664,"start":665,"enrollment":229,"conditions":782,"interventions":783},[68],[667,668],[652,670,671,672,673,674,675],{"trials":785,"activeCount":78},[],{"trials":787,"activeCount":78},[],{"trials":789,"activeCount":78},[],{"intervention":791,"totalTrials":74,"cells":792},"Daunorubicin",{"EARLY_PHASE1":793,"PHASE1":795,"PHASE2":797,"PHASE3":810,"PHASE4":812,"NA":814},{"trials":794,"activeCount":78},[],{"trials":796,"activeCount":78},[],{"trials":798,"activeCount":78},[799],{"nctId":800,"briefTitle":801,"status":247,"phases":802,"primaryCompletion":250,"completion":250,"start":803,"enrollment":74,"conditions":804,"interventions":809},"NCT04562792","Low Dose Daunorubicin in Pediatric Relapsed\u002FRefractory Acute Leukemia",[68],"2020-05-08",[805,806,807,808],"Relapsed Pediatric ALL","Relapsed Pediatric AML","Refractory Acute Myeloid Leukemia","Refractory Acute Lymphoblastic Leukemia",[791],{"trials":811,"activeCount":78},[],{"trials":813,"activeCount":78},[],{"trials":815,"activeCount":78},[],{"intervention":817,"totalTrials":74,"cells":818},"Pravastatin",{"EARLY_PHASE1":819,"PHASE1":821,"PHASE2":834,"PHASE3":836,"PHASE4":838,"NA":840},{"trials":820,"activeCount":78},[],{"trials":822,"activeCount":78},[823],{"nctId":824,"briefTitle":825,"status":247,"phases":826,"primaryCompletion":827,"completion":827,"start":828,"enrollment":829,"conditions":830,"interventions":832},"NCT02360826","Statin Distribution",[67],"2016-07-05","2014-06-17",32,[831],"Drug Distribution",[817,833],"Simvastatin",{"trials":835,"activeCount":78},[],{"trials":837,"activeCount":78},[],{"trials":839,"activeCount":78},[],{"trials":841,"activeCount":78},[],{"intervention":833,"totalTrials":74,"cells":843},{"EARLY_PHASE1":844,"PHASE1":846,"PHASE2":852,"PHASE3":854,"PHASE4":856,"NA":858},{"trials":845,"activeCount":78},[],{"trials":847,"activeCount":78},[848],{"nctId":824,"briefTitle":825,"status":247,"phases":849,"primaryCompletion":827,"completion":827,"start":828,"enrollment":829,"conditions":850,"interventions":851},[67],[831],[817,833],{"trials":853,"activeCount":78},[],{"trials":855,"activeCount":78},[],{"trials":857,"activeCount":78},[],{"trials":859,"activeCount":78},[],{"intervention":861,"totalTrials":74,"cells":862},"Hydroxyurea",{"EARLY_PHASE1":863,"PHASE1":865,"PHASE2":878,"PHASE3":880,"PHASE4":882,"NA":884},{"trials":864,"activeCount":78},[],{"trials":866,"activeCount":78},[867],{"nctId":868,"briefTitle":869,"status":247,"phases":870,"primaryCompletion":871,"completion":872,"start":873,"enrollment":874,"conditions":875,"interventions":877},"NCT01506544","Pharmacokinetics (PK) of Liquid Hydroxyurea in Pediatric Patients With Sickle Cell Anemia",[67],"2013-12","2014-01","2011-12",39,[876],"Sickle Cell Anemia",[861],{"trials":879,"activeCount":78},[],{"trials":881,"activeCount":78},[],{"trials":883,"activeCount":78},[],{"trials":885,"activeCount":78},[],{"intervention":887,"totalTrials":74,"cells":888},"Rosuvastatin",{"EARLY_PHASE1":889,"PHASE1":891,"PHASE2":904,"PHASE3":906,"PHASE4":908,"NA":910},{"trials":890,"activeCount":78},[],{"trials":892,"activeCount":78},[893],{"nctId":894,"briefTitle":895,"status":247,"phases":896,"primaryCompletion":897,"completion":897,"start":898,"enrollment":899,"conditions":900,"interventions":902},"NCT02364258","Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients",[67],"2017-12-27","2014-07",28,[901],"Dyslipidemia",[887,903],"Atorvastatin",{"trials":905,"activeCount":78},[],{"trials":907,"activeCount":78},[],{"trials":909,"activeCount":78},[],{"trials":911,"activeCount":78},[],{"intervention":913,"totalTrials":74,"cells":914},"Fecal Microbiota Transplantation",{"EARLY_PHASE1":915,"PHASE1":917,"PHASE2":931,"PHASE3":933,"PHASE4":935,"NA":937},{"trials":916,"activeCount":78},[],{"trials":918,"activeCount":78},[919],{"nctId":920,"briefTitle":921,"status":247,"phases":922,"primaryCompletion":923,"completion":923,"start":924,"enrollment":925,"conditions":926,"interventions":930},"NCT02108821","Fecal Microbiota Transplantation in Pediatric Patients",[67],"2016-09-30","2014-03",23,[927,928,929],"Inflammatory Bowel Diseases (IBD)","Crohn's Disease (CD)","Ulcerative Colitis (UC)",[913],{"trials":932,"activeCount":78},[],{"trials":934,"activeCount":78},[],{"trials":936,"activeCount":78},[],{"trials":938,"activeCount":78},[],{"intervention":940,"totalTrials":74,"cells":941},"Posaconazole",{"EARLY_PHASE1":942,"PHASE1":944,"PHASE2":956,"PHASE3":958,"PHASE4":960,"NA":962},{"trials":943,"activeCount":78},[],{"trials":945,"activeCount":78},[946],{"nctId":947,"briefTitle":948,"status":247,"phases":949,"primaryCompletion":950,"completion":950,"start":951,"enrollment":952,"conditions":953,"interventions":955},"NCT02358499","Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children",[67],"2018-12-31","2015-01",31,[954],"Fungal Infections",[940],{"trials":957,"activeCount":78},[],{"trials":959,"activeCount":78},[],{"trials":961,"activeCount":78},[],{"trials":963,"activeCount":78},[],{"intervention":965,"totalTrials":74,"cells":966},"GD2 CAR modified Tri-virus specific cytotoxic t-cells",{"EARLY_PHASE1":967,"PHASE1":969,"PHASE2":979,"PHASE3":981,"PHASE4":983,"NA":985},{"trials":968,"activeCount":78},[],{"trials":970,"activeCount":78},[971],{"nctId":972,"briefTitle":973,"status":247,"phases":974,"primaryCompletion":951,"completion":951,"start":975,"enrollment":22,"conditions":976,"interventions":978},"NCT01460901","Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed\u002FRefractory Neuroblastoma",[67],"2012-10",[977],"Neuroblastoma",[965],{"trials":980,"activeCount":78},[],{"trials":982,"activeCount":78},[],{"trials":984,"activeCount":78},[],{"trials":986,"activeCount":78},[],{"intervention":988,"totalTrials":74,"cells":989},"Contraceptive",{"EARLY_PHASE1":990,"PHASE1":1006,"PHASE2":1008,"PHASE3":1010,"PHASE4":1012,"NA":1014},{"trials":991,"activeCount":78},[992],{"nctId":993,"briefTitle":994,"status":247,"phases":995,"primaryCompletion":996,"completion":997,"start":998,"enrollment":999,"conditions":1000,"interventions":1005},"NCT04423068","Inpatient Adolescent Contraception",[66],"2022-04-01","2023-04-04","2020-12-10",25,[1001,26,1002,1003,1004],"Pregnancy Related","Contraceptive Usage","Contraception Behavior","Pregnancy",[988],{"trials":1007,"activeCount":78},[],{"trials":1009,"activeCount":78},[],{"trials":1011,"activeCount":78},[],{"trials":1013,"activeCount":78},[],{"trials":1015,"activeCount":78},[],{"intervention":1017,"totalTrials":229,"cells":1018},"montelukast",{"EARLY_PHASE1":1019,"PHASE1":1021,"PHASE2":1023,"PHASE3":1025,"PHASE4":1027,"NA":1029},{"trials":1020,"activeCount":78},[],{"trials":1022,"activeCount":78},[],{"trials":1024,"activeCount":78},[],{"trials":1026,"activeCount":78},[],{"trials":1028,"activeCount":78},[],{"trials":1030,"activeCount":78},[1031,1042],{"nctId":1032,"briefTitle":1033,"status":247,"phases":1034,"completion":1035,"start":1036,"enrollment":1037,"conditions":1038,"interventions":1041},"NCT00148603","Montelukast in the Treatment of Duodenal Eosinophilia",[71],"2006-12","2005-09",24,[1039,1040],"Eosinophilic Gastroenteritis","Dyspepsia",[1017],{"nctId":1043,"briefTitle":1044,"status":318,"phases":1045,"primaryCompletion":1046,"completion":1046,"start":873,"enrollment":29,"conditions":1047,"interventions":1049},"NCT01458418","A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children",[71],"2015-02",[1048],"Eosinophilic Esophagitis",[1050,1051],"Montelukast","5 mg Montelukast",{"intervention":903,"totalTrials":229,"cells":1053},{"EARLY_PHASE1":1054,"PHASE1":1056,"PHASE2":1062,"PHASE3":1064,"PHASE4":1066,"NA":1068},{"trials":1055,"activeCount":78},[],{"trials":1057,"activeCount":78},[1058],{"nctId":894,"briefTitle":895,"status":247,"phases":1059,"primaryCompletion":897,"completion":897,"start":898,"enrollment":899,"conditions":1060,"interventions":1061},[67],[901],[887,903],{"trials":1063,"activeCount":78},[],{"trials":1065,"activeCount":78},[],{"trials":1067,"activeCount":78},[],{"trials":1069,"activeCount":78},[1070],{"nctId":1071,"briefTitle":1072,"status":247,"phases":1073,"completion":1074,"start":1075,"enrollment":551,"conditions":1076,"interventions":1078},"NCT00120133","Atorvastatin (Lipitor) to Prevent Bone Pain",[71],"2007-12","2004-12",[1077],"Osteoporosis",[903],{"intervention":1080,"totalTrials":229,"cells":1081},"Cinacalcet",{"EARLY_PHASE1":1082,"PHASE1":1084,"PHASE2":1095,"PHASE3":1097,"PHASE4":1099,"NA":1101},{"trials":1083,"activeCount":78},[],{"trials":1085,"activeCount":78},[1086],{"nctId":1087,"briefTitle":1088,"status":247,"phases":1089,"primaryCompletion":1090,"completion":1090,"start":1091,"enrollment":11,"conditions":1092,"interventions":1094},"NCT00195936","Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets",[67],"2008-02","2005-06",[1093],"Hypophosphatemic Rickets, X-Linked Dominant",[1080],{"trials":1096,"activeCount":78},[],{"trials":1098,"activeCount":78},[],{"trials":1100,"activeCount":78},[],{"trials":1102,"activeCount":78},[1103],{"nctId":1104,"briefTitle":1105,"status":452,"phases":1106,"primaryCompletion":1107,"completion":1107,"start":1108,"enrollment":78,"conditions":1109,"interventions":1111},"NCT00844740","Calcimimetics in Hypophosphatemic Rickets",[71],"2012-03-01","2009-03-01",[1110],"Familial Hypophosphatemic Rickets",[1080],{"intervention":1113,"totalTrials":74,"cells":1114},"Atomoxetine Hydrochloride",{"EARLY_PHASE1":1115,"PHASE1":1117,"PHASE2":1119,"PHASE3":1121,"PHASE4":1123,"NA":1125},{"trials":1116,"activeCount":78},[],{"trials":1118,"activeCount":78},[],{"trials":1120,"activeCount":78},[],{"trials":1122,"activeCount":78},[],{"trials":1124,"activeCount":78},[],{"trials":1126,"activeCount":78},[1127],{"nctId":1128,"briefTitle":1129,"status":247,"phases":1130,"primaryCompletion":1131,"completion":1132,"start":1133,"enrollment":1134,"conditions":1135,"interventions":1137},"NCT03154359","Atomoxetine PBPK-PD Clinical Study",[],"2022-06-01","2022-06-16","2017-12-12",51,[1136],"ADHD",[1113],{"intervention":1139,"totalTrials":74,"cells":1140},"Naloxone",{"EARLY_PHASE1":1141,"PHASE1":1143,"PHASE2":1145,"PHASE3":1147,"PHASE4":1149,"NA":1151},{"trials":1142,"activeCount":78},[],{"trials":1144,"activeCount":78},[],{"trials":1146,"activeCount":78},[],{"trials":1148,"activeCount":78},[],{"trials":1150,"activeCount":78},[],{"trials":1152,"activeCount":78},[1153],{"nctId":1154,"briefTitle":1155,"status":247,"phases":1156,"primaryCompletion":1157,"completion":1158,"start":1159,"enrollment":1160,"conditions":1161,"interventions":1165},"NCT01531439","Comparison of Two Naloxone Infusion Rates on the Postoperative Recovery of Patients Undergoing Spine Fusion Surgery",[71],"2015-05-01","2016-12-01","2011-11",84,[1162,1163,1164],"Pain, Postoperative","Postoperative Nausea and Vomiting","Scoliosis",[1139,1139],{"intervention":1167,"totalTrials":74,"cells":1168},"Potassium Citrate",{"EARLY_PHASE1":1169,"PHASE1":1171,"PHASE2":1173,"PHASE3":1175,"PHASE4":1177,"NA":1179},{"trials":1170,"activeCount":78},[],{"trials":1172,"activeCount":78},[],{"trials":1174,"activeCount":78},[],{"trials":1176,"activeCount":78},[],{"trials":1178,"activeCount":78},[],{"trials":1180,"activeCount":78},[1181],{"nctId":1182,"briefTitle":1183,"status":452,"phases":1184,"completion":1185,"start":1186,"enrollment":78,"conditions":1187,"interventions":1189},"NCT00120731","Effects of Potassium Citrate in Urine of Children With Elevated Calcium in Urine and Kidney Stones",[71],"2007-05","2005-07",[1188],"Kidney Calculi",[1167,1190],"Acetazolamide",{"intervention":1190,"totalTrials":74,"cells":1192},{"EARLY_PHASE1":1193,"PHASE1":1195,"PHASE2":1197,"PHASE3":1199,"PHASE4":1201,"NA":1203},{"trials":1194,"activeCount":78},[],{"trials":1196,"activeCount":78},[],{"trials":1198,"activeCount":78},[],{"trials":1200,"activeCount":78},[],{"trials":1202,"activeCount":78},[],{"trials":1204,"activeCount":78},[1205],{"nctId":1182,"briefTitle":1183,"status":452,"phases":1206,"completion":1185,"start":1186,"enrollment":78,"conditions":1207,"interventions":1208},[71],[1188],[1167,1190],{"intervention":1210,"totalTrials":74,"cells":1211},"IV tylenol",{"EARLY_PHASE1":1212,"PHASE1":1214,"PHASE2":1216,"PHASE3":1218,"PHASE4":1220,"NA":1222},{"trials":1213,"activeCount":78},[],{"trials":1215,"activeCount":78},[],{"trials":1217,"activeCount":78},[],{"trials":1219,"activeCount":78},[],{"trials":1221,"activeCount":78},[],{"trials":1223,"activeCount":78},[1224],{"nctId":1225,"briefTitle":1226,"status":247,"phases":1227,"primaryCompletion":1228,"completion":1229,"start":1230,"enrollment":1231,"conditions":1232,"interventions":1233},"NCT02881996","The Impact of IV Acetaminophen on Pain After Appendectomy for Perforated Appendicitis",[71],"2016-06","2016-08","2014-06",90,[33],[1210,1234,1235],"No IV tylenol","Ketorolac",{"intervention":1234,"totalTrials":74,"cells":1237},{"EARLY_PHASE1":1238,"PHASE1":1240,"PHASE2":1242,"PHASE3":1244,"PHASE4":1246,"NA":1248},{"trials":1239,"activeCount":78},[],{"trials":1241,"activeCount":78},[],{"trials":1243,"activeCount":78},[],{"trials":1245,"activeCount":78},[],{"trials":1247,"activeCount":78},[],{"trials":1249,"activeCount":78},[1250],{"nctId":1225,"briefTitle":1226,"status":247,"phases":1251,"primaryCompletion":1228,"completion":1229,"start":1230,"enrollment":1231,"conditions":1252,"interventions":1253},[71],[33],[1210,1234,1235],{"intervention":1235,"totalTrials":74,"cells":1255},{"EARLY_PHASE1":1256,"PHASE1":1258,"PHASE2":1260,"PHASE3":1262,"PHASE4":1264,"NA":1266},{"trials":1257,"activeCount":78},[],{"trials":1259,"activeCount":78},[],{"trials":1261,"activeCount":78},[],{"trials":1263,"activeCount":78},[],{"trials":1265,"activeCount":78},[],{"trials":1267,"activeCount":78},[1268],{"nctId":1225,"briefTitle":1226,"status":247,"phases":1269,"primaryCompletion":1228,"completion":1229,"start":1230,"enrollment":1231,"conditions":1270,"interventions":1271},[71],[33],[1210,1234,1235],{"intervention":1273,"totalTrials":74,"cells":1274},"Whole Genome Sequencing",{"EARLY_PHASE1":1275,"PHASE1":1277,"PHASE2":1279,"PHASE3":1281,"PHASE4":1283,"NA":1285},{"trials":1276,"activeCount":78},[],{"trials":1278,"activeCount":78},[],{"trials":1280,"activeCount":78},[],{"trials":1282,"activeCount":78},[],{"trials":1284,"activeCount":78},[],{"trials":1286,"activeCount":78},[1287],{"nctId":1288,"briefTitle":1289,"status":247,"phases":1290,"primaryCompletion":1291,"completion":1291,"start":1292,"enrollment":1293,"conditions":1294,"interventions":1296},"NCT05062629","United States Hypophosphatasia Molecular Research Center",[],"2026-02-25","2021-08-24",29,[1295],"Hypophosphatasia",[1273],{"intervention":1298,"totalTrials":74,"cells":1299},"PEG 3350",{"EARLY_PHASE1":1300,"PHASE1":1302,"PHASE2":1304,"PHASE3":1306,"PHASE4":1308,"NA":1310},{"trials":1301,"activeCount":78},[],{"trials":1303,"activeCount":78},[],{"trials":1305,"activeCount":78},[],{"trials":1307,"activeCount":78},[],{"trials":1309,"activeCount":78},[],{"trials":1311,"activeCount":78},[1312],{"nctId":1313,"briefTitle":1314,"status":318,"phases":1315,"primaryCompletion":1316,"completion":1316,"start":1035,"enrollment":1317,"conditions":1318,"interventions":1320},"NCT00467350","Comparison Trial of Enema vs. PEG 3350 for Constipation",[71],"2009-05",80,[1319],"Constipation",[1298,1321],"milk and molasses enema",{"intervention":1321,"totalTrials":74,"cells":1323},{"EARLY_PHASE1":1324,"PHASE1":1326,"PHASE2":1328,"PHASE3":1330,"PHASE4":1332,"NA":1334},{"trials":1325,"activeCount":78},[],{"trials":1327,"activeCount":78},[],{"trials":1329,"activeCount":78},[],{"trials":1331,"activeCount":78},[],{"trials":1333,"activeCount":78},[],{"trials":1335,"activeCount":78},[1336],{"nctId":1313,"briefTitle":1314,"status":318,"phases":1337,"primaryCompletion":1316,"completion":1316,"start":1035,"enrollment":1317,"conditions":1338,"interventions":1339},[71],[1319],[1298,1321],{"intervention":1341,"totalTrials":74,"cells":1342},"Carnitine",{"EARLY_PHASE1":1343,"PHASE1":1345,"PHASE2":1347,"PHASE3":1349,"PHASE4":1351,"NA":1353},{"trials":1344,"activeCount":78},[],{"trials":1346,"activeCount":78},[],{"trials":1348,"activeCount":78},[],{"trials":1350,"activeCount":78},[],{"trials":1352,"activeCount":78},[],{"trials":1354,"activeCount":78},[1355],{"nctId":1356,"briefTitle":1357,"status":247,"phases":1358,"completion":1359,"start":1360,"enrollment":1361,"conditions":1362,"interventions":1365},"NCT00351234","Carnitine Levels and Carnitine Supplementation in Type I Diabetes",[],"2007-04","2004-10",200,[1363,1364],"Diabetes Mellitus, Type I","Hypoglycemia",[1341],{"intervention":1367,"totalTrials":74,"cells":1368},"Trimethoprim-sulfamethoxazole",{"EARLY_PHASE1":1369,"PHASE1":1371,"PHASE2":1373,"PHASE3":1375,"PHASE4":1377,"NA":1379},{"trials":1370,"activeCount":78},[],{"trials":1372,"activeCount":78},[],{"trials":1374,"activeCount":78},[],{"trials":1376,"activeCount":78},[],{"trials":1378,"activeCount":78},[],{"trials":1380,"activeCount":78},[1381],{"nctId":1382,"briefTitle":1383,"status":318,"phases":1384,"primaryCompletion":975,"completion":975,"start":1385,"enrollment":1386,"conditions":1387,"interventions":1389},"NCT00867789","Antibiotics Versus Placebo in the Treatment of Abscesses in the Emergency Department",[71],"2009-03",140,[1388],"Abscess",[1367,1390],"Sugar pill",{"intervention":1390,"totalTrials":74,"cells":1392},{"EARLY_PHASE1":1393,"PHASE1":1395,"PHASE2":1397,"PHASE3":1399,"PHASE4":1401,"NA":1403},{"trials":1394,"activeCount":78},[],{"trials":1396,"activeCount":78},[],{"trials":1398,"activeCount":78},[],{"trials":1400,"activeCount":78},[],{"trials":1402,"activeCount":78},[],{"trials":1404,"activeCount":78},[1405],{"nctId":1382,"briefTitle":1383,"status":318,"phases":1406,"primaryCompletion":975,"completion":975,"start":1385,"enrollment":1386,"conditions":1407,"interventions":1408},[71],[1388],[1367,1390],{"intervention":1410,"totalTrials":74,"cells":1411},"Ampicillin, gentamicin, clindamycin, flagyl, ceftazidime",{"EARLY_PHASE1":1412,"PHASE1":1414,"PHASE2":1416,"PHASE3":1418,"PHASE4":1420,"NA":1422},{"trials":1413,"activeCount":78},[],{"trials":1415,"activeCount":78},[],{"trials":1417,"activeCount":78},[],{"trials":1419,"activeCount":78},[],{"trials":1421,"activeCount":78},[],{"trials":1423,"activeCount":78},[1424],{"nctId":1425,"briefTitle":1426,"status":247,"phases":1427,"completion":1428,"start":617,"enrollment":1429,"conditions":1430,"interventions":1431},"NCT00195923","Prospective Randomized Evaluation of Antibiotic Regimen Following Appendectomy for Perforated Appendicitis",[],"2007-01",100,[33],[1410],{"intervention":1051,"totalTrials":74,"cells":1433},{"EARLY_PHASE1":1434,"PHASE1":1436,"PHASE2":1438,"PHASE3":1440,"PHASE4":1442,"NA":1444},{"trials":1435,"activeCount":78},[],{"trials":1437,"activeCount":78},[],{"trials":1439,"activeCount":78},[],{"trials":1441,"activeCount":78},[],{"trials":1443,"activeCount":78},[],{"trials":1445,"activeCount":78},[1446],{"nctId":1043,"briefTitle":1044,"status":318,"phases":1447,"primaryCompletion":1046,"completion":1046,"start":873,"enrollment":29,"conditions":1448,"interventions":1449},[71],[1048],[1050,1051],{"intervention":1451,"totalTrials":74,"cells":1452},"Epidural Analgesia",{"EARLY_PHASE1":1453,"PHASE1":1455,"PHASE2":1457,"PHASE3":1459,"PHASE4":1461,"NA":1463},{"trials":1454,"activeCount":78},[],{"trials":1456,"activeCount":78},[],{"trials":1458,"activeCount":78},[],{"trials":1460,"activeCount":78},[],{"trials":1462,"activeCount":78},[],{"trials":1464,"activeCount":78},[1465],{"nctId":1466,"briefTitle":1467,"status":247,"phases":1468,"primaryCompletion":1469,"completion":1470,"start":1471,"enrollment":1472,"conditions":1473,"interventions":1475},"NCT00413582","Pain Management for Pectus Excavatum Repair",[71],"2010-05","2010-10","2006-10",110,[1474],"Postoperative Pain",[1451,1476],"Patient-Controlled IV Analgesia",{"intervention":1476,"totalTrials":74,"cells":1478},{"EARLY_PHASE1":1479,"PHASE1":1481,"PHASE2":1483,"PHASE3":1485,"PHASE4":1487,"NA":1489},{"trials":1480,"activeCount":78},[],{"trials":1482,"activeCount":78},[],{"trials":1484,"activeCount":78},[],{"trials":1486,"activeCount":78},[],{"trials":1488,"activeCount":78},[],{"trials":1490,"activeCount":78},[1491],{"nctId":1466,"briefTitle":1467,"status":247,"phases":1492,"primaryCompletion":1469,"completion":1470,"start":1471,"enrollment":1472,"conditions":1493,"interventions":1494},[71],[1474],[1451,1476],{"intervention":1496,"totalTrials":74,"cells":1497},"Acthrel",{"EARLY_PHASE1":1498,"PHASE1":1500,"PHASE2":1502,"PHASE3":1504,"PHASE4":1506,"NA":1508},{"trials":1499,"activeCount":78},[],{"trials":1501,"activeCount":78},[],{"trials":1503,"activeCount":78},[],{"trials":1505,"activeCount":78},[],{"trials":1507,"activeCount":78},[],{"trials":1509,"activeCount":78},[1510],{"nctId":1511,"briefTitle":1512,"status":452,"phases":1513,"primaryCompletion":1514,"completion":1515,"start":1514,"enrollment":78,"conditions":1516,"interventions":1518},"NCT01373372","Corticotropin Releasing Hormone (CRH) Responsiveness in Children With Functional Dyspepsia",[71],"2016-12","2017-03",[1517],"Functional Dyspepsia",[1496],{"intervention":1520,"totalTrials":74,"cells":1521},"Estradiol cream 0.01%",{"EARLY_PHASE1":1522,"PHASE1":1524,"PHASE2":1526,"PHASE3":1528,"PHASE4":1530,"NA":1532},{"trials":1523,"activeCount":78},[],{"trials":1525,"activeCount":78},[],{"trials":1527,"activeCount":78},[],{"trials":1529,"activeCount":78},[],{"trials":1531,"activeCount":78},[],{"trials":1533,"activeCount":78},[1534],{"nctId":1535,"briefTitle":1536,"status":247,"phases":1537,"primaryCompletion":1538,"completion":1228,"start":1539,"enrollment":1540,"conditions":1541,"interventions":1543},"NCT02218463","Treatment of Prepubertal Labial Adhesions",[71],"2016-05","2014-09",43,[1542],"Prepubertal Labial Adhesions",[1520,1544],"Cetaphil",{"intervention":1544,"totalTrials":74,"cells":1546},{"EARLY_PHASE1":1547,"PHASE1":1549,"PHASE2":1551,"PHASE3":1553,"PHASE4":1555,"NA":1557},{"trials":1548,"activeCount":78},[],{"trials":1550,"activeCount":78},[],{"trials":1552,"activeCount":78},[],{"trials":1554,"activeCount":78},[],{"trials":1556,"activeCount":78},[],{"trials":1558,"activeCount":78},[1559],{"nctId":1535,"briefTitle":1536,"status":247,"phases":1560,"primaryCompletion":1538,"completion":1228,"start":1539,"enrollment":1540,"conditions":1561,"interventions":1562},[71],[1542],[1520,1544],{"intervention":1564,"totalTrials":74,"cells":1565},"5 days of IV antibiotics",{"EARLY_PHASE1":1566,"PHASE1":1568,"PHASE2":1570,"PHASE3":1572,"PHASE4":1574,"NA":1576},{"trials":1567,"activeCount":78},[],{"trials":1569,"activeCount":78},[],{"trials":1571,"activeCount":78},[],{"trials":1573,"activeCount":78},[],{"trials":1575,"activeCount":78},[],{"trials":1577,"activeCount":78},[1578],{"nctId":1579,"briefTitle":1580,"status":247,"phases":1581,"primaryCompletion":1582,"completion":1582,"start":1583,"enrollment":1584,"conditions":1585,"interventions":1586},"NCT00462020","Intravenous Versus Intravenous\u002FOral Antibiotics for Perforated Appendicitis",[71],"2008-11","2007-03",102,[33],[1564,1587],"Home with oral antibiotics when eating",{"intervention":1587,"totalTrials":74,"cells":1589},{"EARLY_PHASE1":1590,"PHASE1":1592,"PHASE2":1594,"PHASE3":1596,"PHASE4":1598,"NA":1600},{"trials":1591,"activeCount":78},[],{"trials":1593,"activeCount":78},[],{"trials":1595,"activeCount":78},[],{"trials":1597,"activeCount":78},[],{"trials":1599,"activeCount":78},[],{"trials":1601,"activeCount":78},[1602],{"nctId":1579,"briefTitle":1580,"status":247,"phases":1603,"primaryCompletion":1582,"completion":1582,"start":1583,"enrollment":1584,"conditions":1604,"interventions":1605},[71],[33],[1564,1587],{"intervention":1607,"totalTrials":74,"cells":1608},"6-Mercaptopurine",{"EARLY_PHASE1":1609,"PHASE1":1611,"PHASE2":1613,"PHASE3":1615,"PHASE4":1617,"NA":1619},{"trials":1610,"activeCount":78},[],{"trials":1612,"activeCount":78},[],{"trials":1614,"activeCount":78},[],{"trials":1616,"activeCount":78},[],{"trials":1618,"activeCount":78},[],{"trials":1620,"activeCount":78},[1621],{"nctId":1622,"briefTitle":1623,"status":247,"phases":1624,"primaryCompletion":871,"completion":871,"start":1625,"enrollment":113,"conditions":1626,"interventions":1627},"NCT01324336","Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and Tablets",[],"2011-07",[667],[1607]]